Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Opalesque Radio

SRI/Environment-led/Impact Investing - Where and how to allocate to, expected returns
Radio Feature 45: Alfred Evans in conversation with Sona Blessing
 
Wednesday, April 04, 2012
radio Alfred Evans is founder and CEO of Islan, and Director of Bunge Emissions Group. He has 20 years of professional experience in emerging markets, energy and environment. Before founding Islan Asset Management, Alfred was a manager in Bunge’s Financial Services Group where he held several senior positions over his seven-year tenure, including as CEO of Ecoinvest Carbon SA -acquired by Bunge under his guidance.
          In this radio feature he share his expertise on the evolution and outlook for SRI/impact - driven investments, investment opportunities in Africa and emerging markets for sustainable and impact investments, and available markets in emissions, forestry and agriculture...

 Download this feature as MP3 (11.93 MB)

 
Listen to the complete feature
SRI/Environment-led/Impact Investing - Where and how to allocate to, expected returns

Duration: 13:01 

 

Or listen to selected sub-features
  • Q1 - Could you start by walking us through the evolution and outlook for impact and SRI-driven investments?

    Duration: 02:27 


  • Q2 - Could you elaborate on the opportunities in Africa and in other emerging markets for sustainable and impact investments?

    Duration: 03:36 


  • Q3 - Impact investing and SRI investment prospects in other emerging markets outside of Africa - which would they be and why?

    Duration: 00:51 


  • Q4 - What could be the expected returns for investors looking to invest in these strategies?

    Duration: 01:54 


  • Q5 - How does SRI and impact investment tie in with the available markets and assets in emissions, forestry and agriculture?

    Duration: 04:11 



Radio Link
  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its